RACHEL HEIBEIN: Open Payments
NPI 1225481245 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 50 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $896 · 2025 $1,258
Food & beverage: $1,140Education: $118
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $296 |
| ABBVIE INC. | 14 | $271 |
| Janssen Biotech, Inc. | 4 | $167 |
| Bioventus LLC | 3 | $115 |
| AstraZeneca Pharmaceuticals LP | 2 | $103 |
| PFIZER INC. | 3 | $62 |
| UCB, Inc. | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Fresenius Kabi USA, LLC | 3 | $56 |
| Organon LLC | 1 | $25 |
Products named: SKYRIZI, TREMFYA, KRYSTEXXA, GELSYN-3, SAPHNELO, OTEZLA, XELJANZ, Bimzelx.
Industry payments across MD — which companies pay providers there.
